Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hirsch BA"" wg kryterium: Autor


Tytuł:
The National Surgical Quality Improvement Program 30-Day Challenge: Microsurgical Breast Reconstruction Outcomes Reporting Reliability
Autorzy:
Austin D. Chen
Parisa Kamali, MD
Anmol S. Chattha, BA
Alexandra Bucknor, MBBS, MSc
Justin B. Cohen, MD, MHS
Patrick P. Bletsis, BSc
Renata Flecha-Hirsch, BA
Adam M. Tobias, MD
Bernard T. Lee, MD, MBA, MPH
Samuel J. Lin, MD, MBA
Pokaż więcej
Temat:
Surgery
RD1-811
Źródło:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 3, p e1643 (2018)
Opis pliku:
electronic resource
Relacje:
http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001643; https://doaj.org/toc/2169-7574
Dostęp URL:
https://doaj.org/article/27cda10ac4c34d5f8fe6b12ca9403f4b  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse
Autorzy:
Brunstein, CG
Hirsch, BA
Miller, JS
McGlennen, RC
Verfaillie, CM
McGlave, PB
Weisdorf, DJ
Pokaż więcej
Źródło:
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 26(11):1173-1177
Czasopismo naukowe
Tytuł:
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Autorzy:
Chisholm KM; Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.
Smith J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Heerema-McKenney AE; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Choi JK; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Hirsch BA; Division of Laboratory Medicine, University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, USA.
Raimondi SC; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Wang YC; Children's Oncology Group, Monrovia, California, USA.
Dang A; Children's Oncology Group, Monrovia, California, USA.
Alonzo TA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Sung L; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Aplenc R; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Gamis AS; Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kahwash SB; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30251. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/mortality
Leukemia, Myeloid, Acute*/pathology
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Young Adult ; Cytogenetic Analysis ; Disease-Free Survival ; Down Syndrome/genetics ; Gene Fusion ; Mutation Rate
Czasopismo naukowe
Tytuł:
Deletion at an 1q24 locus reveals a critical role of long noncoding RNA DNM3OS in skeletal development.
Autorzy:
Yu TT; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Xu QF; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Li SY; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Huang HJ; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Dugan S; Department of Medical Genetics, Children's Hospital and Clinics of Minnesota, Minneapolis, MI, 55404, USA.
Shao L; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Roggenbuck JA; Department of Neurology, Ohio State University Medical Center, Columbus, OH, 43210, USA.
Liu XT; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Liu HZ; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China.
Hirsch BA; University of Minnesota Medical Center-Fairview, Minneapolis, MI, 55404, USA.
Yue S; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China. .
Liu C; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China. .
Cheng SY; Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, 211166, Nanjing, P. R. China. .
Pokaż więcej
Źródło:
Cell & bioscience [Cell Biosci] 2021 Mar 02; Vol. 11 (1), pp. 47. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Autorzy:
Pardo LM; Hematologics, Inc., Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Voigt AP; Hematologics, Inc., Seattle, Washington.
Alonzo TA; Children's Oncology Group, Monrovia, California.; University of Southern California, Los Angeles, California.
Wilson ER; Hematologics, Inc., Seattle, Washington.
Gerbing RB; Children's Oncology Group, Monrovia, California.
Paine DJ; Hematologics, Inc., Seattle, Washington.
Dai F; Hematologics, Inc., Seattle, Washington.
Menssen AJ; Hematologics, Inc., Seattle, Washington.
Raimondi SC; St. Jude's Children's Research Hospital, Memphis, Tennessee.
Hirsch BA; University of Minnesota Medical Center, Minneapolis, Minnesota.
Gamis AS; Children's Mercy Hospitals & Clinics, Kansas City, Missouri.
Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Children's Oncology Group, Monrovia, California.
Wells DA; Hematologics, Inc., Seattle, Washington.
Brodersen LE; Hematologics, Inc., Seattle, Washington.
Loken MR; Hematologics, Inc., Seattle, Washington.
Pokaż więcej
Źródło:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2020 Jan; Vol. 98 (1), pp. 52-56. Date of Electronic Publication: 2019 Jul 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
CD56 Antigen/*metabolism
Leukemia, Myeloid, Acute/*metabolism
Cohort Studies ; Female ; Flow Cytometry/methods ; Humans ; Immunophenotyping/methods ; Kruppel-Like Transcription Factors/metabolism ; Male ; Medical Oncology/methods ; Pediatrics ; Phenotype ; Prognosis ; Repressor Proteins/metabolism ; Transcriptome/physiology
Czasopismo naukowe
Tytuł:
Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
Autorzy:
Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: .
Shago M; Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON, Canada.
Mikhail FM; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Raimondi SC; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA.
Loh ML; Department of Pediatrics, UCSF Medical Center-Mission Bay, San Francisco, CA, USA.
Raetz EA; Department of Pediatrics, New York University Medical Center, New York, NY, USA.
Borowitz MJ; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Wood BL; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Maloney KW; Children's Hospital of Colorado, Aurora, CO, USA.
Mattano LA Jr; HARP Pharma Consulting, Mystic, CT, USA.
Larsen EC; Maine Children's Cancer Program, Scarborough, ME, USA.
Gastier-Foster J; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pathology, The Ohio State University, Columbus, OH, USA.
Stonerock E; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Ell D; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Kahwash S; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Devidas M; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
Harvey RC; University of New Mexico Cancer Center, Albuquerque, NM, USA.
Chen IL; University of New Mexico Cancer Center, Albuquerque, NM, USA.
Willman CL; University of New Mexico Cancer Center, Albuquerque, NM, USA.
Hunger SP; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Winick NJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carroll WL; Department of Pediatrics, New York University Medical Center, New York, NY, USA.
Rao KW; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH, USA.
Pokaż więcej
Źródło:
Cancer genetics [Cancer Genet] 2019 Oct; Vol. 238, pp. 62-68. Date of Electronic Publication: 2019 Jul 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diploidy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Child ; Chromosomes, Human ; Humans ; Karyotyping ; Mosaicism
Czasopismo naukowe
Tytuł:
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
Autorzy:
Rafiee R; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Chauhan L; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Elmasry A; Mansoura University, Mansoura, Egypt.
Loken MR; Hematologics Inc, Seattle, USA.
Pollard J; Dana-Farber/Boston Children's Cancer Center and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Raimondi S; Department of Pathology, St. Jude Children's Hospital, Memphis, TN, USA.
Hirsch BA; Children's Hospitals and Clinic of Minnesota, University of Minnesota, Minneapolis, MN, USA.
Bernstein ID; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gamis AS; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lamba JK; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA. .
Pokaż więcej
Źródło:
Blood cancer journal [Blood Cancer J] 2019 May 21; Vol. 9 (6), pp. 51. Date of Electronic Publication: 2019 May 21.
Typ publikacji:
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Polymorphism, Single Nucleotide*
Antineoplastic Agents, Immunological/*therapeutic use
Gemtuzumab/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Leukemia, Myeloid, Acute/*genetics
ATP Binding Cassette Transporter, Subfamily B/genetics ; Adolescent ; Adult ; Alleles ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Child ; Child, Preschool ; Female ; Gemtuzumab/administration & dosage ; Gemtuzumab/adverse effects ; Genotype ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Male ; Prognosis ; Recurrence ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Autorzy:
Voigt AP; Hematologics, Inc, Seattle, WA, USA.
Brodersen LE; Hematologics, Inc, Seattle, WA, USA .
Alonzo TA; Children's Oncology Group, Monrovia, CA, USA.; University of Southern California, Los Angeles, CA, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Menssen AJ; Hematologics, Inc, Seattle, WA, USA.
Wilson ER; Hematologics, Inc, Seattle, WA, USA.
Kahwash S; Nationwide Children's Hospital, Columbus, OH, USA.
Raimondi SC; St. Jude's Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; University of Minnesota Medical Center, Minneapolis, MN, USA.
Gamis AS; Children's Mercy Hospitals & Clinics, Kansas City, MO, USA.
Meshinchi S; Children's Oncology Group, Monrovia, CA, USA.; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Wells DA; Hematologics, Inc, Seattle, WA, USA.
Loken MR; Hematologics, Inc, Seattle, WA, USA.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2017 Dec; Vol. 102 (12), pp. 2058-2068. Date of Electronic Publication: 2017 Sep 07.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms:
Genotype*
Phenotype*
Leukemia, Myeloid, Acute/*diagnosis
Adolescent ; Bone Marrow Examination ; Child ; Child, Preschool ; Cluster Analysis ; Humans ; Immunophenotyping/methods ; Leukemia, Myeloid, Acute/mortality ; Prognosis ; Regression Analysis ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Chimerism for 20q11.2 microdeletion of GDF5 explains discordant phenotypes in monochorionic-diamniotic twins.
Autorzy:
Meredith MM; Division of Molecular Pathology and Genomics, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota.
Crabb B; Department of Medical Genetics and Genomics, Children's Minnesota, Minneapolis, Minnesota.
Vargas M; Department of Medical Genetics and Genomics, Children's Minnesota, Minneapolis, Minnesota.
Hirsch BA; Division of Molecular Pathology and Genomics, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota.
Pokaż więcej
Źródło:
American journal of medical genetics. Part A [Am J Med Genet A] 2017 Dec; Vol. 173 (12), pp. 3182-3188. Date of Electronic Publication: 2017 Sep 08.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Chimerism*
Chromosome Deletion*
Chromosomes, Human, Pair 20/*genetics
Diseases in Twins/*genetics
Growth Differentiation Factor 5/*genetics
Twins, Monozygotic/*genetics
Diseases in Twins/blood ; Diseases in Twins/diagnosis ; Genotype ; Humans ; In Situ Hybridization, Fluorescence ; Infant, Newborn ; Karyotyping ; Male ; Mosaicism ; Mouth Mucosa ; Phenotype ; Twins
Czasopismo naukowe
Tytuł:
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Autorzy:
Ramamurthy R; University of Washington School of Medicine, Seattle, Washington.
Hughes M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Seattle Children's Hospital, Seattle, Washington.
Morris V; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Bolouri H; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Gerbing RB; Children's Oncology Group, Monrovia, California.
Wang YC; Children's Oncology Group, Monrovia, California.
Loken MR; Hematologics, Inc, Seattle, Washington.
Raimondi SC; Children's Oncology Group, Monrovia, California.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Hirsch BA; Children's Oncology Group, Monrovia, California.; Division of Laboratory Medicine, University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota.
Gamis AS; Children's Oncology Group, Monrovia, California.; Children's Mercy Hospitals & Clinics, Kansas City, Missiouri.
Oehler VG; University of Washington School of Medicine, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Alonzo TA; Keck School of Medical Department of Preventive Medicine, University of Southern California, Los Angeles, California.
Meshinchi S; University of Washington School of Medicine, Seattle, Washington. .; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. .; Seattle Children's Hospital, Seattle, Washington. .; Children's Oncology Group, Monrovia, California. .
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2016 Dec; Vol. 63 (12), pp. 2096-2103. Date of Electronic Publication: 2016 Aug 11.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute/*genetics
MicroRNAs/*analysis
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Leukemia, Myeloid, Acute/mortality ; Male ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Tytuł:
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA.
Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA.
Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2016 Nov 30; Vol. 9 (1), pp. 133. Date of Electronic Publication: 2016 Nov 30.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Autorzy:
Poynter JN; Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address: .
Richardson M; Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States.
Blair CK; Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN 55455, United States.
Roesler MA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
Hirsch BA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, United States.
Nguyen P; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States.
Cioc A; VA Medical Center, Minneapolis, MN 55417, United States.
Warlick E; Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, United States.
Cerhan JR; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, United States.
Ross JA; Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, United States; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.
Pokaż więcej
Źródło:
Cancer epidemiology [Cancer Epidemiol] 2016 Feb; Vol. 40, pp. 134-40. Date of Electronic Publication: 2015 Dec 22.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Leukemia, Myeloid, Acute/*epidemiology
Myelodysplastic Syndromes/*epidemiology
Obesity/*epidemiology
Overweight/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Body Mass Index ; Case-Control Studies ; Female ; Humans ; Leukemia, Myeloid, Acute/etiology ; Logistic Models ; Male ; Middle Aged ; Minnesota/epidemiology ; Myelodysplastic Syndromes/etiology ; Odds Ratio ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł:
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.; Children's Oncology Group, Monrovia, CA, USA.
Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Kentsis A; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College of Cornell University, New York, NY, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Wang YC; Children's Oncology Group, Monrovia, CA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA.
Gamis AS; Children's Oncology Group, Monrovia, CA, USA.; Division of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.; Children's Oncology Group, Monrovia, CA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA. .; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. .; Department of Epidemiology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2015 Oct 20; Vol. 8, pp. 115. Date of Electronic Publication: 2015 Oct 20.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Aminoglycosides/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Gene Expression Regulation, Leukemic/*drug effects
Leukemia, Myeloid/*drug therapy
Acute Disease ; Adolescent ; Adult ; Aminoglycosides/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Bone Marrow/drug effects ; Bone Marrow/metabolism ; Bone Marrow/pathology ; Child ; Child, Preschool ; Female ; Gemtuzumab ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid/genetics ; Leukemia, Myeloid/metabolism ; MEF2 Transcription Factors/genetics ; MEF2 Transcription Factors/metabolism ; Male ; Multivariate Analysis ; Prognosis ; Regression Analysis ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; Risk Factors ; Survival Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Autorzy:
Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, WA , USA.
Ries RE
Gudgeon CJ
Harrington KH
Alonzo TA
Gerbing RB
Raimondi SC
Hirsch BA
Gamis AS
Meshinchi S
Walter RB
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2014 Dec; Vol. 55 (12), pp. 2817-21. Date of Electronic Publication: 2014 Mar 24.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression*
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*mortality
Suppressor of Cytokine Signaling Proteins/*genetics
Adolescent ; Child ; Child, Preschool ; Disease Progression ; Female ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/therapy ; Male ; Neoplasm, Residual ; Pilot Projects ; Prognosis ; RNA, Messenger/genetics ; Recurrence ; Young Adult
Czasopismo naukowe
Tytuł:
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.
Autorzy:
Tarlock K; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.
Alonzo TA; Keck School of Medicine, University of Southern California, Arcadia, CA.; Children's Oncology Group, Arcadia, CA.
Moraleda PP; Hematology and Blood and Marrow Transplant Program, Hospital Universitario Central de Asturias, Oviedo, Spain.
Gerbing RB; Children's Oncology Group, Arcadia, CA.
Raimondi SC; Children's Oncology Group, Arcadia, CA.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Hirsch BA; Children's Oncology Group, Arcadia, CA.; Division of Laboratory Medicine, University of Minnesota Medical Center-Fairview, MN.
Ravindranath Y; Children's Oncology Group, Arcadia, CA.; Carman and Ann Adams Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI.
Lange B; Children's Oncology Group, Arcadia, CA.; Children's Hosp. of Philadelphia, Philadelphia, PA.
Woods WG; Children's Oncology Group, Arcadia, CA.; Aflac Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta.
Gamis AS; Children's Oncology Group, Arcadia, CA.; Children's Mercy Hospitals and Clinics, Kansas City, MO.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.; Children's Oncology Group, Arcadia, CA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2014 Jul; Vol. 166 (2), pp. 254-259. Date of Electronic Publication: 2014 Mar 25.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Translocation, Genetic*
Chromosomes, Human, Pair 6/*genetics
Chromosomes, Human, Pair 9/*genetics
Leukemia, Myeloid, Acute/*genetics
fms-Like Tyrosine Kinase 3/*genetics
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Gene Duplication ; Genes, Neoplasm ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/therapy ; Male ; Neoplasm Proteins/genetics ; Prognosis ; Recurrence ; Remission Induction ; Survival Analysis ; Tandem Repeat Sequences ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies